Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 987

1.

Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.

Wang W, Ding Y, Campbell A, Handy BC, Medeiros LJ, Lin P.

Pathology. 2019 Mar 4. pii: S0031-3025(18)30484-7. doi: 10.1016/j.pathol.2018.10.022. [Epub ahead of print] No abstract available.

PMID:
30846229
2.

Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Collins MS, Miranda RN, Medeiros LJ, Silva de Meneses MP, Iyer SP, Butler CE, Liu J, Clemens MW.

Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S. doi: 10.1097/PRS.0000000000005568.

PMID:
30817555
3.

Pioneers of Breast Implant-Associated Anaplastic Large Cell Lymphoma: History from Case Report to Global Recognition.

Miranda RN, Medeiros LJ, Ferrufino-Schmidt MC, Keech JA Jr, Brody GS, de Jong D, Dogan A, Clemens MW.

Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):7S-14S. doi: 10.1097/PRS.0000000000005564.

PMID:
30817551
4.

American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.

O'Malley DP, Dogan A, Fedoriw Y, Medeiros LJ, Ok CY, Salama ME.

Ann Diagn Pathol. 2019 Feb 6;39:105-110. doi: 10.1016/j.anndiagpath.2019.02.001. [Epub ahead of print]

5.

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma.

Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee H, Westin J, Fowler N, Nastoupil L, Dabaja B.

Int J Radiat Oncol Biol Phys. 2019 Feb 12. pii: S0360-3016(19)30192-0. doi: 10.1016/j.ijrobp.2019.02.002. [Epub ahead of print]

PMID:
30769175
6.

SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.

Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S.

Am J Surg Pathol. 2019 Feb 12. doi: 10.1097/PAS.0000000000001233. [Epub ahead of print]

PMID:
30768440
7.

Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.

Xie W, Hu S, Xu J, Chen Z, Medeiros LJ, Tang G.

Ann Hematol. 2019 Feb 13. doi: 10.1007/s00277-019-03637-7. [Epub ahead of print]

PMID:
30759270
8.

Immune profiling and quantitative analysis decipher the clinical role of immune checkpoint expression in the tumor immune microenvironment of DLBCL.

Xu-Monette Z, Xiao M, Au Q, Padmanabhan R, Xu B, Hoe N, Rodriguez-Perales S, Torres-Ruiz R, Manyam G, Visco C, Miao Y, Tan X, Zhang H, Tzankov A, Wang J, Dybkaer K, Tam W, You H, Bhagat G, Hsi ED, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, van Krieken JH, Winter JN, Westin JR, Pham LV, Medeiros LJ, Rassidakis GZ, Li Y, Freeman GJ, Young KH.

Cancer Immunol Res. 2019 Feb 11. pii: canimm.0439.2018. doi: 10.1158/2326-6066.CIR-18-0439. [Epub ahead of print]

PMID:
30745366
9.

Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.

Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ.

Clin Lymphoma Myeloma Leuk. 2019 Jan 3. pii: S2152-2650(18)31446-0. doi: 10.1016/j.clml.2018.12.016. [Epub ahead of print]

PMID:
30686775
10.

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.

Li L, Sun R, Miao Y, Tran T, Adams L, Roscoe N, Xu B, Manyam GC, Tan X, Zhang H, Xiao M, Tzankov A, Visco C, Dybkaer K, Bhagat G, Tam W, Hsi ED, van Krieken JH, You H, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Zhang M, Winter JN, Medeiros LJ, Rassidakis GZ, Vaupel CA, Li Y, Dakappagari N, Xu-Monette ZY, Young KH.

Mod Pathol. 2019 Jan 21. doi: 10.1038/s41379-018-0193-5. [Epub ahead of print]

PMID:
30666052
11.

Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.

Ye W, Hannigan B, Zalles S, Mehrotra M, Barkoh BA, Williams MD, Cabanillas ME, Edeiken-Monroe B, Hu P, Duose D, Wistuba II, Medeiros LJ, Stewart J, Luthra R, Roy-Chowdhuri S.

Cancer Cytopathol. 2019 Jan 8. doi: 10.1002/cncy.22098. [Epub ahead of print]

PMID:
30620446
12.

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.

Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang MI, Cohen JB, Calzada O, Churnetski MC, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Bast MA, Fenske TS, Narayana Rao Gari S, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns TF, Donovan AM, Wagner-Johnston N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach AE, Landsburg DJ, Glenn M, Inwards DJ, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Fisher RI, Barta SK.

J Clin Oncol. 2019 Feb 20;37(6):471-480. doi: 10.1200/JCO.18.00690. Epub 2019 Jan 7.

PMID:
30615550
13.

Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection.

Patel KP, Ruiz-Cordero R, Chen W, Routbort MJ, Floyd K, Rodriguez S, Galbincea J, Barkoh BA, Hatfield D, Khogeer H, Kanagal-Shamanna R, Yin CC, Zuo Z, Loghavi S, Ok CY, DiNardo CD, Luthra R, Medeiros LJ.

J Mol Diagn. 2019 Jan;21(1):89-98. doi: 10.1016/j.jmoldx.2018.08.002.

PMID:
30577887
14.

t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.

Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z.

J Mol Diagn. 2019 Mar;21(2):343-351. doi: 10.1016/j.jmoldx.2018.10.005. Epub 2018 Dec 19.

PMID:
30576868
15.

Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms.

Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA.

Onco Targets Ther. 2018 Dec 10;11:8937-8942. doi: 10.2147/OTT.S159843. eCollection 2018.

16.

Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors.

Xie W, Wang SA, Hu S, Xu J, Medeiros LJ, Tang G.

Cancer Genet. 2018 Dec;228-229:41-46. doi: 10.1016/j.cancergen.2018.08.002. Epub 2018 Aug 27.

PMID:
30553471
17.

Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration.

Wang RC, Medeiros LJ, Chang KC.

Int J Hematol. 2019 Feb;109(2):133-134. doi: 10.1007/s12185-018-02566-x. Epub 2018 Dec 5. No abstract available.

PMID:
30519992
18.

Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.

Kanagal-Shamanna R, Jain P, Patel KP, Routbort M, Bueso-Ramos C, Alhalouli T, Khoury JD, Luthra R, Ferrajoli A, Keating M, Jain N, Burger J, Estrov Z, Wierda W, Kantarjian HM, Medeiros LJ.

Cancer. 2019 Feb 15;125(4):559-574. doi: 10.1002/cncr.31831. Epub 2018 Dec 3.

PMID:
30508305
19.

Levels of CD8+ tumor infiltrating lymphocytes correlate with disease burden in bone marrow of therapy Naïve multiple myeloma patients.

Hidalgo-Lopez JE, Higa MG, Ferrian S, Lin P, Blando J, Medeiros LJ, Bueso-Ramos CE.

Ann Diagn Pathol. 2018 Nov 28. pii: S1092-9134(18)30370-8. doi: 10.1016/j.anndiagpath.2018.11.008. [Epub ahead of print] No abstract available.

PMID:
30509755
20.

Utility of JAK2 V617F allelic burden in distinguishing chronic Myelomonocytic leukemia from primary myelofibrosis with Monocytosis.

Hu Z, Ramos CB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Xu J, Verstovsek S, Lin P.

Hum Pathol. 2018 Nov 15. pii: S0046-8177(18)30423-4. doi: 10.1016/j.humpath.2018.10.026. [Epub ahead of print]

PMID:
30447300
21.

Chronic Myeloid Leukemia: Beyond BCR-ABL1.

Zhou T, Medeiros LJ, Hu S.

Curr Hematol Malig Rep. 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6. Review.

PMID:
30370478
22.

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.

Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC.

Adv Radiat Oncol. 2018 Jul 12;3(4):639-646. doi: 10.1016/j.adro.2018.07.001. eCollection 2018 Oct-Dec.

23.

CD123 expression patterns and selective targeting with a CD123-specific antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.

Angelova E, Audette C, Kovtun Y, Daver N, Wang SA, Pierce S, Konoplev SN, Khogeer H, Jorgensen JL, Konopleva M, Zweidler-McKay PA, Medeiros LJ, Kantarjian HM, Jabbour EJ, Khoury JD.

Haematologica. 2018 Oct 25. pii: haematol.2018.205252. doi: 10.3324/haematol.2018.205252. [Epub ahead of print]

24.

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.

Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC.

Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e51-e61. doi: 10.1016/j.clml.2018.09.002. Epub 2018 Sep 10.

PMID:
30360985
25.

Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.

Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC.

Oncotarget. 2018 Sep 28;9(76):34449. doi: 10.18632/oncotarget.26205. eCollection 2018 Sep 28.

26.

Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.

Rassidakis GZ, Herold N, Myrberg IH, Tsesmetzis N, Rudd SG, Henter JI, Schaller T, Ng SB, Chng WJ, Yan B, Ng CH, Ravandi F, Andreeff M, Kantarjian HM, Medeiros LJ, Xagoraris I, Khoury JD.

Blood Cancer J. 2018 Oct 19;8(11):98. doi: 10.1038/s41408-018-0134-z.

27.

Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation.

Garces S, Yin CC, Patel KP, Khoury JD, Manning JT Jr, Li S, Xu J, Pina-Oviedo S, Johnson MR, González S, Molgó M, Ruiz-Cordero R, Medeiros LJ.

Mod Pathol. 2019 Jan;32(1):16-26. doi: 10.1038/s41379-018-0152-1. Epub 2018 Oct 15.

PMID:
30323237
28.

Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.

Hidalgo-Lόpez JE, Kanagal-Shamanna R, Quesada AE, Gong Z, Wang W, Hu S, Medeiros LJ, Bassett RL Jr, d'Orcy E, Yin CC, Cortes J, Jabbour EJ, Kantarjian HM, Bueso-Ramos CE.

Cancer. 2018 Oct 1;124(19):3849-3855. doi: 10.1002/cncr.31663. Epub 2018 Oct 15.

PMID:
30321462
29.

Granular B-acute lymphoblastic leukemia: Ultrastructural characterization of cytoplasmic granules.

Wu H, Liu B, Li B, Wang Y, Wang H, Medeiros LJ, Zhang B, Wang W.

Leuk Res. 2018 Oct;73:105-107. doi: 10.1016/j.leukres.2018.08.016. Epub 2018 Sep 1. No abstract available.

PMID:
30268960
30.

IgM plasma cell myeloma in the era of novel therapy: a clinicopathological study of 17 cases.

Angelova EA, Li S, Wang W, Bueso-Ramos C, Tang G, Medeiros LJ, Lin P.

Hum Pathol. 2019 Feb;84:321-334. doi: 10.1016/j.humpath.2018.09.008. Epub 2018 Sep 25.

PMID:
30266252
31.

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma.

Zhang J, Medeiros LJ, Young KH.

Front Oncol. 2018 Sep 10;8:351. doi: 10.3389/fonc.2018.00351. eCollection 2018. Review.

32.

Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events.

Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD.

Leuk Res. 2018 Oct;73:86-94. doi: 10.1016/j.leukres.2018.09.006. Epub 2018 Sep 17.

PMID:
30248580
33.

Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era.

Montes-Moreno S, Routbort MJ, Lohman EJ, Barkoh BA, Kanagal-Shamanna R, Bueso-Ramos CE, Singh RR, Medeiros LJ, Luthra R, Patel KP.

PLoS One. 2018 Sep 17;13(9):e0204218. doi: 10.1371/journal.pone.0204218. eCollection 2018.

34.

B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.

Li L, Zhang J, Chen J, Xu-Monette ZY, Miao Y, Xiao M, Young KH, Wang S, Medeiros LJ, Wang M, Ford RJ, Pham LV.

Blood. 2018 Oct 25;132(17):1805-1817. doi: 10.1182/blood-2018-03-841015. Epub 2018 Sep 12.

PMID:
30209121
35.

Breast implant-associated anaplastic large cell lymphoma: a review.

Quesada AE, Medeiros LJ, Clemens MW, Ferrufino-Schmidt MC, Pina-Oviedo S, Miranda RN.

Mod Pathol. 2019 Feb;32(2):166-188. doi: 10.1038/s41379-018-0134-3. Epub 2018 Sep 11. Review.

PMID:
30206414
36.

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.

Ok CY, Medeiros LJ, Thakral B, Tang G, Jain N, Jabbour E, Pierce SA, Konoplev S.

Mod Pathol. 2019 Jan;32(1):48-58. doi: 10.1038/s41379-018-0112-9. Epub 2018 Sep 4.

PMID:
30181564
37.

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.

Jain P, Kanagal-Shamanna R, Zhang S, Ahmed M, Ghorab A, Zhang L, Ok CY, Li S, Hagemeister F, Zeng D, Gong T, Chen W, Badillo M, Nomie K, Fayad L, Medeiros LJ, Neelapu S, Fowler N, Romaguera J, Champlin R, Wang L, Wang ML.

Br J Haematol. 2018 Nov;183(4):578-587. doi: 10.1111/bjh.15567. Epub 2018 Sep 2.

PMID:
30175400
38.

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia.

Ok CY, Loghavi S, Sui D, Wei P, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Tang G, Tang Z, Jorgensen JL, Luthra R, Ravandi F, Kantarjian HM, DiNardo CD, Medeiros LJ, Wang SA, Patel KP.

Haematologica. 2019 Feb;104(2):305-311. doi: 10.3324/haematol.2018.191148. Epub 2018 Aug 31.

39.

Kikuchi disease: an unusual case with features suggesting an infectious aetiology.

Chang C, Lin SH, Medeiros LJ, Chang KC.

Pathology. 2018 Oct;50(6):694-697. doi: 10.1016/j.pathol.2018.04.005. Epub 2018 Aug 23. No abstract available.

PMID:
30145070
40.

P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse-free survival.

Assi R, Gur HD, Loghavi S, Konoplev SN, Konopleva M, Daver N, Tashakori M, Kadia T, Routbort M, Salem A, Kanagal-Shamanna R, Quesada A, Jabbour EJ, Kornblau SM, Medeiros LJ, Kantarjian H, Khoury JD.

Am J Hematol. 2018 Nov;93(11):1376-1383. doi: 10.1002/ajh.25255. Epub 2018 Sep 23.

PMID:
30117185
41.

A multimodality work-up of patients with Hypereosinophilia.

Hu Z, Boddu PC, Loghavi S, Miranda RN, Goswami M, Medeiros LJ, Tam W, Orazi A, Verstovsek S, Wang SA.

Am J Hematol. 2018 Nov;93(11):1337-1346. doi: 10.1002/ajh.25247. Epub 2018 Sep 26.

PMID:
30105844
42.

TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization.

Chen Z, Lin TC, Bi X, Lu G, Dawson BC, Miranda R, Medeiros LJ, McNiece I, McCarty N.

Leukemia. 2019 Feb;33(2):469-486. doi: 10.1038/s41375-018-0222-x. Epub 2018 Aug 8.

43.

Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.

Garces S, Khoury JD, Kanagal-Shamanna R, Salem A, Wang SA, Ok CY, Hu S, Patel KP, Routbort MJ, Luthra R, Tang G, Schlette EJ, Bueso-Ramos CE, Medeiros LJ, Loghavi S.

Hum Pathol. 2018 Dec;82:215-231. doi: 10.1016/j.humpath.2018.07.030. Epub 2018 Aug 4.

PMID:
30086334
44.

CT and 18F- FDG-PET-CT Findings in Secondary Adrenal Lymphoma with Pathologic Correlation.

Altinmakas E, Üçışık-Keser FE, Medeiros LJ, Ng CS.

Acad Radiol. 2018 Jul 31. pii: S1076-6332(18)30339-8. doi: 10.1016/j.acra.2018.06.025. [Epub ahead of print]

PMID:
30076085
45.

Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories.

Loghavi S, Sui D, Wei P, Garcia-Manero G, Pierce S, Routbort MJ, Jabbour EJ, Pemmaraju N, Kanagal-Shamanna R, Gur HD, Hu S, Zuo Z, Medeiros LJ, Kantarjian HM, Khoury JD.

Blood Adv. 2018 Aug 14;2(15):1807-1816. doi: 10.1182/bloodadvances.2018019224.

46.

Higher body mass index is associated with better survival in patients with myelodysplastic syndromes.

Jabbar KJ, Yin CC, Bueso-Ramos CE, Luthra R, Medeiros LJ, Zuo Z.

Leuk Res. 2018 Aug;71:63-66. doi: 10.1016/j.leukres.2018.07.008. Epub 2018 Jul 10. No abstract available.

PMID:
30015105
47.

Advances in pathological understanding of high-grade B cell lymphomas.

Li S, Lin P, Medeiros LJ.

Expert Rev Hematol. 2018 Aug;11(8):637-648. doi: 10.1080/17474086.2018.1494567. Epub 2018 Jul 10. Review.

PMID:
29989509
48.

Neurosyphilis manifesting as trigeminal nerve dysfunction.

Medeiros LJDS, Marchiori E, Bahia PRV.

Rev Soc Bras Med Trop. 2018 May-Jun;51(3):404. doi: 10.1590/0037-8682-0157-2017. No abstract available.

49.

Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience.

Angelova EA, Medeiros LJ, Wang W, Muzzafar T, Lu X, Khoury JD, Ravandi F, Patel KP, Hu Z, Kanagal-Shamanna R.

Mod Pathol. 2018 Nov;31(11):1717-1732. doi: 10.1038/s41379-018-0093-8. Epub 2018 Jun 28.

PMID:
29955146
50.

Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.

Oishi N, Brody GS, Ketterling RP, Viswanatha DS, He R, Dasari S, Mai M, Benson HK, Sattler CA, Boddicker RL, McPhail ED, Bennani NN, Harless CA, Singh K, Clemens MW, Medeiros LJ, Miranda RN, Feldman AL.

Blood. 2018 Aug 2;132(5):544-547. doi: 10.1182/blood-2017-12-821868. Epub 2018 Jun 19. No abstract available.

PMID:
29921615

Supplemental Content

Loading ...
Support Center